Cargando…
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
As a result of cross-species transmission in December 2019, the coronavirus disease 2019 (COVID-19) became a serious endangerment to human health and the causal agent of a global pandemic. Although the number of infected people has decreased due to effective management, novel methods to treat critic...
Autores principales: | Chen, Lijun, Qu, Jingjing, Kalyani, Farhin Shaheed, Zhang, Qi, Fan, Lingzhi, Fang, Yangxin, Li, Yifei, Xiang, Charlie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858603/ https://www.ncbi.nlm.nih.gov/pubmed/35187617 http://dx.doi.org/10.1007/s00018-021-04096-y |
Ejemplares similares
-
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy
por: Qu, Jingjing, et al.
Publicado: (2021) -
Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine
por: Chen, Lijun, et al.
Publicado: (2021) -
Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases
por: Chen, Lijun, et al.
Publicado: (2019) -
Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation
por: Qu, Jingjing, et al.
Publicado: (2022) -
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
por: Liu, Li, et al.
Publicado: (2021)